Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
OBJECTIVES: We performed a national survey to update hepatocellular carcinoma (HCC) epidemiology in Brazil and determined the clinical and epidemiological profiles of patients with HCC in different Brazilian regions. METHODS: Data from 29 centers included 1,405 patients diagnosed with HCC from 2004 to 2009. RESULTS: The median age was 59 (1-92 years old; 78% male). At diagnosis, females were older than males (median age: 62 vs. 59 years old respectively; p<0.0001). Ninety-eight percent of the patients had cirrhosis (1279/1308). Hepatitis C virus was the main etiology (54%), followed by hepatitis B virus (16%) and alcohol (14%). In Southeastern and Southern Brazil, hepatitis C virus accounted for over 55% of cases. In the Northeast and North, hepatitis C virus accounted for less than 50%, and hepatitis B virus accounted for 22-25% of cases; hepatitis B was more prevalent in the Northern than in the Southern regions. Some 43%, 35%, and 22% of patients were in early, intermediate, and advanced stages respectively. Initial therapies for HCC included chemoembolization or embolization (36%), percutaneous ablation (13%), liver resection (7%), and sorafenib (1%). Liver transplantation was performed in 242 patients (19%), but it was the initial therapy for only 56 patients (4%). CONCLUSION: The epidemiology, classification, and therapy selection for HCC varied among Brazilian regions. Hepatitis C infection was the most common etiology of liver cirrhosis; chemoembolization was the most common therapy employed. Liver cirrhosis was the main risk factor for HCC development in Brazil.
Main Authors: | , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Faculdade de Medicina / USP
2010
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010001200010 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1807-59322010001200010 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1807-593220100012000102011-03-21Clinical and epidemiological aspects of hepatocellular carcinoma in BrazilCarrilho,Flair JoseKikuchi,LucianaBranco,FernandaGoncalves,Carlos SandovalMattos,Angelo Aves de Hepatocellular carcinoma Epidemiology Liver cancer Brazil Treatment OBJECTIVES: We performed a national survey to update hepatocellular carcinoma (HCC) epidemiology in Brazil and determined the clinical and epidemiological profiles of patients with HCC in different Brazilian regions. METHODS: Data from 29 centers included 1,405 patients diagnosed with HCC from 2004 to 2009. RESULTS: The median age was 59 (1-92 years old; 78% male). At diagnosis, females were older than males (median age: 62 vs. 59 years old respectively; p<0.0001). Ninety-eight percent of the patients had cirrhosis (1279/1308). Hepatitis C virus was the main etiology (54%), followed by hepatitis B virus (16%) and alcohol (14%). In Southeastern and Southern Brazil, hepatitis C virus accounted for over 55% of cases. In the Northeast and North, hepatitis C virus accounted for less than 50%, and hepatitis B virus accounted for 22-25% of cases; hepatitis B was more prevalent in the Northern than in the Southern regions. Some 43%, 35%, and 22% of patients were in early, intermediate, and advanced stages respectively. Initial therapies for HCC included chemoembolization or embolization (36%), percutaneous ablation (13%), liver resection (7%), and sorafenib (1%). Liver transplantation was performed in 242 patients (19%), but it was the initial therapy for only 56 patients (4%). CONCLUSION: The epidemiology, classification, and therapy selection for HCC varied among Brazilian regions. Hepatitis C infection was the most common etiology of liver cirrhosis; chemoembolization was the most common therapy employed. Liver cirrhosis was the main risk factor for HCC development in Brazil.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.65 n.12 20102010-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010001200010en10.1590/S1807-59322010001200010 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Carrilho,Flair Jose Kikuchi,Luciana Branco,Fernanda Goncalves,Carlos Sandoval Mattos,Angelo Aves de |
spellingShingle |
Carrilho,Flair Jose Kikuchi,Luciana Branco,Fernanda Goncalves,Carlos Sandoval Mattos,Angelo Aves de Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil |
author_facet |
Carrilho,Flair Jose Kikuchi,Luciana Branco,Fernanda Goncalves,Carlos Sandoval Mattos,Angelo Aves de |
author_sort |
Carrilho,Flair Jose |
title |
Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil |
title_short |
Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil |
title_full |
Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil |
title_fullStr |
Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil |
title_full_unstemmed |
Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil |
title_sort |
clinical and epidemiological aspects of hepatocellular carcinoma in brazil |
description |
OBJECTIVES: We performed a national survey to update hepatocellular carcinoma (HCC) epidemiology in Brazil and determined the clinical and epidemiological profiles of patients with HCC in different Brazilian regions. METHODS: Data from 29 centers included 1,405 patients diagnosed with HCC from 2004 to 2009. RESULTS: The median age was 59 (1-92 years old; 78% male). At diagnosis, females were older than males (median age: 62 vs. 59 years old respectively; p<0.0001). Ninety-eight percent of the patients had cirrhosis (1279/1308). Hepatitis C virus was the main etiology (54%), followed by hepatitis B virus (16%) and alcohol (14%). In Southeastern and Southern Brazil, hepatitis C virus accounted for over 55% of cases. In the Northeast and North, hepatitis C virus accounted for less than 50%, and hepatitis B virus accounted for 22-25% of cases; hepatitis B was more prevalent in the Northern than in the Southern regions. Some 43%, 35%, and 22% of patients were in early, intermediate, and advanced stages respectively. Initial therapies for HCC included chemoembolization or embolization (36%), percutaneous ablation (13%), liver resection (7%), and sorafenib (1%). Liver transplantation was performed in 242 patients (19%), but it was the initial therapy for only 56 patients (4%). CONCLUSION: The epidemiology, classification, and therapy selection for HCC varied among Brazilian regions. Hepatitis C infection was the most common etiology of liver cirrhosis; chemoembolization was the most common therapy employed. Liver cirrhosis was the main risk factor for HCC development in Brazil. |
publisher |
Faculdade de Medicina / USP |
publishDate |
2010 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010001200010 |
work_keys_str_mv |
AT carrilhoflairjose clinicalandepidemiologicalaspectsofhepatocellularcarcinomainbrazil AT kikuchiluciana clinicalandepidemiologicalaspectsofhepatocellularcarcinomainbrazil AT brancofernanda clinicalandepidemiologicalaspectsofhepatocellularcarcinomainbrazil AT goncalvescarlossandoval clinicalandepidemiologicalaspectsofhepatocellularcarcinomainbrazil AT mattosangeloavesde clinicalandepidemiologicalaspectsofhepatocellularcarcinomainbrazil |
_version_ |
1756432091626602496 |